The Oncogenic Potential of Endometrial Polyps
- 1 November 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Obstetrics & Gynecology
- Vol. 116 (5), 1197-1205
- https://doi.org/10.1097/aog.0b013e3181f74864
Abstract
To systematically review and summarize the medical literature regarding the association of menopausal status, uterine bleeding, and polyp size and risk of malignancy among women undergoing polyp resection. We supplemented a search of entries in electronic databases with references cited in original studies and review articles to identify studies assessing the risk of malignancy for patients undergoing polypectomy. Key word searches were performed using the words “endometrial polyp,” “malignancy,” “ultrasound,” “saline sonohysterography,” “hysteroscopy,” and “histopathology.” We evaluated abstracted data and performed quantitative analyses in observational studies assessing the effects of menopausal status, vaginal bleeding, and polyp size on the risk of malignancy in patients undergoing polyp resection (n=1,552). For each study with binary outcomes, relative risks with 95% confidence intervals (CIs) were calculated. Estimates of relative risk were calculated using fixed and random-effects models. Homogeneity was tested across the studies. Sensitivity analyses were performed to determine the effects of individual studies on the overall effect estimates. Publication bias was assessed using Egger test. Seventeen studies met inclusion criteria for this review. Among women found to have endometrial polyps, the prevalence of premalignant or malignant polyps was 5.42% (214 of 3,946) in postmenopausal women compared with 1.7% (68 of 3,997) in reproductive-aged women (relative risk 3.86; 95% CI 2.92–5.11). The prevalence of endometrial neoplasia within polyps in women with symptomatic bleeding was 4.15% (195 of 4,697) compared with 2.16% (85 of 3,941) for those without bleeding (relative risk 1.97; 95% CI 1.24–3.14). Among symptomatic postmenopausal women with endometrial polyps, 4.47% (88 of 1,968) had a malignant polyp in comparison to 1.51% (25 of 1,654) asymptomatic postmenopausal women (relative risk 3.36; 95% CI 1.45–7.80). Based on data from observational studies, both symptomatic vaginal bleeding and postmenopausal status in women with endometrial polyps are associated with an increased risk of endometrial malignancy.This publication has 47 references indexed in Scilit:
- Heterogeneity in endometrial expression of aromatase in polyp-bearing uteriHuman Reproduction, 2007
- Aromatase and cyclooxygenase-2 expression in endometrial polyps during the menstrual cycleGynecological Endocrinology, 2006
- The malignant potential of endometrial polypsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2004
- Predicting atypia inside endometrial polyps.Journal of Ultrasound in Medicine, 2002
- HMGI-C and HMGI(Y) Immunoreactivity Correlates with Cytogenetic Abnormalities in Lipomas, Pulmonary Chondroid Hamartomas, Endometrial Polyps, and Uterine Leiomyomas and is Compatible with Rearrangement of the HMGI-C and HMGI(Y) GenesLaboratory Investigation, 2000
- Predictive value of transvaginal sonography performed before routine diagnostic hysteroscopy for evaluation of infertilityFertility and Sterility, 2000
- Amplification and expression of theHMGIC gene in a benign endometrial polypGenes, Chromosomes and Cancer, 1998
- An endometrial polyp with a rearrangement of HMGI-C underlying a complex cytogenetic rearrangement involving chromosomes 2 and 12Cancer Genetics and Cytogenetics, 1996
- Clonal 6p21 rearrangement is restricted to the mesenchymal component of an endometrial polypGenes, Chromosomes and Cancer, 1992
- Carcinosarcoma (Malignant Mixed Mesodermal Tumor) of the UterusInternational Journal of Gynecological Pathology, 1990